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1. Introduction 
Although allergic rhinitis and asthma have been assessed and treated as separate diseases, 
they often occur together. The connection between asthma and rhinitis is not a new 
discovery. This association has been recognized since earlier times. In the second century, 
Galen hypothesized that sinonasal disease caused lung disease through a direct anatomic 
connection. But, the nature of the link between the nose and the lung has been poorly 
understood until recent years (McFadden, 1986). Because the prevalence rates of rhinitis and 
asthma, as with all allergic diseases, are increasing worldwide, there is a growing interest in 
the interaction between upper and lower airways (Bousquet et al.,ARIA Workshop Group. 
World Health Organization, 2001). 
Allergic rhinitis (AR) is the most common atopic disease all over the world affecting almost 
10% to 30% of population (Berger, 2003; Settipane, 2003). Although it generally is not 
considered a severe disorder, the socioeconomic costs of AR are substantial . It adversely 
affects quality of life of the patients, work productivity and school performance as well as 
increasing health care costs (Bachert et al., 2002; Meltzer et al., 2004). Patients who have 
asthma and rhinitis tend to have more severe disease with higher treatment costs. Treatment 
of rhinitis may improve asthma control, and early treatment of allergies may prevent the 
development of asthma (Marple, 2010). 
The connection between upper and lower airways has become a topic of great interest over 
the past few decades. It is now well established that rhinitis and asthma frequently co-exist, 
with approximately 20-50% of AR patients have concomitant asthma and over the 80% of 
asthmatics have nasal symptoms (Bousquet et al., 2003; Braunstahl & Fokkens, 2003). 
During this time of period, a body of evidence concerning the relationship between allergic 
rhinitis and asthma lead to the concept of unified airways or “one airway one disease”. 
Recent advances in the understanding and knowledge of the underlying mechanisms has 
been integrated into the “Allergic rhinitis and its impact on asthma” international report 
(Bousquet et al., ARIA Workshop, 2001). This document have been provided an 
comprehensive overview of current knowledge on allergic rhinitis and asthma, and 
evidence-based guidelines for the treatment. Neverthless not all patients with rhinitis 
present with asthma, the reason why are unknown. The “united airway disease” hypothesis 
proposes that upper and lower airway disease are both manifestations of a single 






2. Epidemiologic evidences 
Several cross-sectional studies have demonstrated that allergic rhinitis, rhinosinusitis and 
asthma frequently coexist in the same patients, despite some methodologic limitations 
(Leynaert et al., 2000). In fact, allergic rhinitis is a ubiquitous disorder in patients with 
asthma. Because the prevalence of allergic rhinitis among patients with asthma is as high as 
90% when the diagnosis of rhinitis was made by using strict diagnostic criteria. (Kapsali et 
al.,1997). The prevalence of allergic rhinitis among patients with asthma is as much as 80% 
which is significantly higher than the 20% prevalence rate in the general population. 
However, up to 40% of patients with allergic rhinitis suffer from asthma symptoms but only 
5% to 10% of the general population (Danielsson & Jessen, 1997). 
The Copenhagen Allergy Study investigated the frequency of asthma and rhinitis related to 
exposure to pollen, animal dander or mites. For people with pollen allergy, 41% of those 
with pollen-related rhinitis also had pollen-related asthma. Pollen-related asthma was 
almost not present (0.1%) in those without pollen-related rhinitis (Linneberg et al., 2001). 
Most patients with asthma have complaints of seasonal or perennial allergic rhinitis. It has 
been shown however, that perennial rhinitis is a risk factor for asthma, independent of 
allergy. By investigating cross-sectional data from the European Community Respiratory 
Health Survey. Leynaert et al found the adjusted odds ratios for the association between 
perennial rhinitis and asthma to be 8.1 among atopic and 11.6 among nonatopic subjects 20 
to 44 years old. (Leynaert et al.,1999). Similarly, Guerra et al reported that the presence of 
rhinitis had a strong predictive value for the adult-onset asthma in both atopic and 
nonatopic patients regarding to skin test responses . In their study, there was a tendency of 
more stronger in the group of subjects with high total IgE levels (Guerra et al., 2002). 
3. Etiopathogenesis 
Allergic disorders such as allergic rhinitis and asthma, have a multifactorial origin. Both 
diseases are characterized by chronic airway inflammation based on common genetic and 
environmental factors. Rhinitis and asthma are often co-exist, and they share common 
causative risk factors including genetic such as atopy, and environmental exposure. Same 
triggers that provoke the diseases of the nose and the lungs contribute to the development 
of the allergic airway syndrome, and comprise inhalant allergens, viral infection, cold-dry 
air, tobacco smoke and air pollution (Bachert et al., 2004; Braunstahl, 2005; Slavin, 2008). 
The inflammation is a central component of both conditions, in which eosinophils, mast cells 
and T-lymphocytes are predominant effector cells. As antigen-presenting cells, dendritic 
cells form a network that is localized within the epithelium and submucosa of the entire 
respiratory mucosa, capture allergens, break them into allergenic peptides, and migrate to 
lymph nodes, where they present them to naive CD4+ T lymphocytes. After sensitization 
process and production of allergen specific IgE antibodies by B cells, their binding to high-
affinity IgE receptors (FcRI) on the surface of mast cells and basophils, rendering them 
“sensitized”. Within minutes of contact of sensitized individuals with allergens, the IgE-
allergen interaction takes place, leading to mast cell and basophil degranulation and the 
release of preformed mediators such as histamine and tryptase, and the de novo generation 
of other mediators, including cysteinyl leukotrienes (CysLTs) and prostaglandins, some of 
which induce the early-phase symptoms. The late-phase response is characterized by the 
recruitment and activation of inflammatory cells like eosinophils, basophils and T cells into 
the mucosa of end-organ. This infiltration of inflammatory cells can also be orchestrated by 
www.intechopen.com
 
The Impact of Allergic Rhinitis on Asthma: Current View 
 
35 
T-helper type 2 (Th2) cells within the local microenvironment. It is likely that cell migration 
is due to the chemokines and cytokines released by the primary effector cells acutely and 
over several hours after allergen exposure leading to chronic on-going inflammation and the 
development of hyperresponsiveness (Rimmer & Ruhno, 2006; Sin & Togias, 2011). 
The natural course of atopic disorders is called the “atopic march”. It has been suggested 
that atopic dermatitis is a starting point for subsequent allergic disease according to this 
theory (Spergel, 2005). The German Multicenter Atopy study evaluated the atopic march in 
1314 children during a 7-year study period. The authors found that 46% of children with 
severe atopic dermatitis had an increased risk of early wheezing compared to patients with 
mild atopic dermatitis (32%) (Lau et al.,2002). However, another study of Illi S et al was 
found to be not completely consistent with the hypothesis in which atopic dermatitis 
preceded wheezing in 56% whereas wheezing preceded atopic dermatitis in 33% (Illi et 
al.,2004). Furthermore, the presence of BHR and rhinitis or both for the development of 
clinical asthma has traditionally been interpreted as the progression of a common airway 
diseases because they are associated with atopic background. 
Yet, the question remains as to why some individuals only manifest symptoms of rhinitis 
and not asthma. The hypothesis would be that those patients may still be part of the 
continuum, but have a milder form of the disease. If so, not only are their lower airways less 
affected (no asthma), but their upper airways should be less severe as well (Pawankar, 
2006). In supporting this hypothesis, Hanes et al, have reported that patients with AR and 
concomitant asthma showed more severe nasal symptoms when they were exposed to cold-
dry air than if they had AR alone ( Hanes et al., 2006). 
4. Clinical aspects 
Asthma and rhinitis also represent the two ends of the clinical spectrum in the respiratory 
tract in which have wide range of changing severity. Allergic rhinitis alone without 
bronchial hyperresponsiveness is a mildest form of the spectrum (Togias, 2003). However, 
from previous studies also known that patients with rhinitis and no clinical evidence of 
asthma may have BHR to inhaled allergens and chemical or physical stimulants (Ramsdale, 
et al.,1985). Some individuals with allergic rhinitis exhibit only seasonal lung symptoms. 
This patients have been shown increased bronchial reactivity during the natural exposure or 
experimental setting to allergen and also nonspecific stimuli as well which may be thought 
as subclinical asthma (Boulet et al., 1989). Therefore, presence of BHR accompanying allergic 
or non-allergic rhinitis is considered as high risk factor for onset of asthma on follow-up. 
But, the factors that determine the progression of rhinitis to asthma are not yet clear. 
The effect of rhinitis on the onset of asthma has been investigated in longitudinal studies. 
The one study of the Settipane et al, which had a 23-year follow-up, demonstrated that 
allergic rhinitis at inclusion resulted in a 3-fold risk of asthma development compared to the 
group without rhinitis (Settipane et al., 1994). Similarly, patients aged 18 to 45 years with 
hay fever have been shown to be at increased risk for asthma in a prospective cohort study 
in Finland (Huovinen et al., 1999). 
Patients with rhinitis have been reported three times more likely to develop asthma than 
healthy control subjects. Therefore, it is suggested that rhinitis is an important risk factor for 
the development of asthma, especially when bronchial hyperresponsiveness (BHR) is 
present. 
One of the main clinical features of asthma is an increase in non-specific airway 






patients with allergic rhinitis without clinical evidence of asthma when exposed to an 
allergen to which they were sensitized (Boulay & Boulet, 2003). However, which factors 
determine BHR in these subjects are clearly unknown. The development of BHR can depend 
on duration of an inflammatory process, such as the one that has been described in the 
lower airways of adult subjects with allergic rhinitis, or on other factors. BHR seems to 
reflect not only the airway inflammation but also the remodelling process. (Foresi et al., 
1997; Polosa et al., 2000). 
BHR among patients with hay fever has been shown to increase during the pollen season 
and to be predictive of the onset of lower airway symptoms (Braman et al., 1987; Madonini 
et al., 1987). In a study of Prieto et al, airway responsiveness to either methacholine or 
adenosine monophosphate was found significantly increased in patients with allergic 
rhinitis alone during the season compared with out of the pollen season. In addition, BHR in 
the asthmatic range was detected during the season in these subjects (Prieto et al., 2002). A 
recent paper by Sin et al. showed that in contrast to the population with both allergic rhinitis 
and asthma, patients with seasonal allergic rhinitis alone did not show a higher degree of 
airway hyperresponsiveness to exercise challenge test when compared to the methacholine 
challenge test during the pollen season (Sin et al., 2009). 
Furthermore, Ciprandi et al, evaluated patients with perennial allergic rhinitis symptoms 
alone. The authors observed that 54 patients out of 100 showed positive methacholine 
challenge test and impairment of spirometric parameters especially reduced forced 
expiratory flow at 25 and 75% of pulmonary volume (FEF25-75) values as a sensitive measure 
of lower airways (Ciprandi et al., 2004). A study of patients with allergic rhinitis showed 
impaired lung function. A lack of bronchodilator response to deep inhalation is a 
characteristic physiological abnormality of asthmatic patients. People with rhinitis had 
blunted response to a deep inhalation suggesting altered airway smooth muscle function 
(Skloot & Togias, 2003). 
It has also been shown that BHR was associated with longer duration of AR and more 
severe nasal inflammation in the absence of asthma symptoms. Based on these data, the 
current concept is that AR precedes asthma in most patients, and worsening of one disease 
negatively affects the course of asthma. It has been postulated that patients with asthma and 
broad extent symptoms of rhinitis may have more severe asthma than those asthmatic 
patients who have minimal or no rhinitis (DREAMS study). From this point of view, it has 
been suggested that the severity of rhinitis and asthma follows a parallel track in correlation 
with the overall severity of the chronic allergic respiratory syndrome that allows for cross-
talk between the upper and lower airways (Togias, 2003). 
Allergic rhinitis may also be contributing factor in 25% to 30% of patients with acute 
maxillary sinusitis and in as many as 60% to 80% of patients with chronic sinusitis (Spector, 
1997). At least, allergic rhinitis is associated with, and probably a predisposing factor in the 
development of rhinosinusitis (Meltzer et al., 2004). Despite the pathophysiologic link 
between allergic rhinitis and asthma have been well-studied, understanding of paranasal 
sinus diseases and its possible relationship with asthma still remain largely unclear. Chronic 
upper airway diseases include allergic rhinitis, non-allergic rhinitis (NAR), chronic 
rhinosinusitis (CRS) with and without nasal polyposis, and occupational rhinitis. They are 
commonly associated with asthma, and increase the complexity of management and costs 
Bousquet et al., 2009). The overall prevalence of CRS have been reported 10.9% in Europe 
and it was found to be more common in smokers. 
 In children, nasal sinus disease may lead to less asthma control. Peroni et al. studied the CT 
findings in children with severe asthma. They concluded that severe asthma patients appear 
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to have the most relevant abnormalities on CT scanning of the paranasal sinuses (Peroni et 
al., 2007). 
Co-morbidity of other upper airway diseases including chronic rhinosinusitis with or 
without nasal polyps have also been linked to asthma severity. Many studies have reported 
that the severity of nasal and sinus disease parallel that of the lower airway disease 
(Pearlman et al., 2009; Ponte et al., 2008). On the other hand, the presence of nasal polyposis 
accompanying chronic rhinosinusitis and the duration of diseases were found to be 
correlated with extensive paranasal sinus computed tomography findings, and were related 
to the severity of asthma in adults (Dursun et al., 2006). 
Sinus disease and lower airway comorbidity often present as severe clinical symptoms of 
the diseases such as nasal polyps, aspirin-exacerbated respiratory disease (AERD), and late-
onset severe intrinsic asthma. However, many patients with aspirin hypersensitivity appear 
with SCUAD (extensive nasal polyposis and anosmia) and accompanying severe asthma 
(Bousquet et al., 2009). 
AERD is a clinical syndrome combining from nasal polyps, chronic hypertrophic 
eosinophilic sinusitis, asthma and sensitivity to aspirin and other non-steroidal anti-
inflammatory drugs that inhibits cyclooxygenase-1 (COX-1) enzymes. Its prevalence rises to 
10-20% of asthmatics and up to 30-40% in those asthmatics with nasal polyposis despite 
occurring in 0.3-0.9% of the general population. Asthma may precede the sinonasal disease 
or develop later. Patients with AERD suffer from frequent attacks of upper and lower 
airway reactions such as nasal congestion with anosmi, rhinorrhea, progression to 
pansinusitis and nasal polyps, and also bronchospasm (Lee et al., 2011). Nasal polyps are 
consistently associated with severe asthma. It has been reported that patients with nasal 
polyposis and asthma have the highest rates of exacerbation and hospital admissions 
(Ceylan et al., 2007). 
 In fact, most severe forms of both upper and lower airway disease may occur in nonatopic 
patients. AERD develops according to a pattern, characterized by a sequence of symptoms. 
First, persistent rhinitis, appearing at a mean age of 29 years, then asthma, aspirin 
intolerance, and finally nasal polyposis. In half of the patients, asthma is severe, and steroid 
dependent (Szczeklik et al., 2000). 
5. Proposed mechanisms for the interaction between upper and lower 
airways 
The mechanisms by which allergic rhinitis may be a risk factor for asthma are not entirely 
understood, although a few studies have addressed this question. It seems that allergic 
rhinitis and asthma result from similar inflammatory processes induced by allergens in the 
upper as well as in the lower airways of sensitized subjects. The nose and lung should thus 
be seen as a continuum, with “information” travelling in both directions, rather than as two 
distinct compartments. In this regard, the concept of “united airways” has been proposed, 
and increasing numbers of studies have agreed with this model (Boulay & Boulet, 2003; 
Rimmer & Ruhno, 2006). The main difference between the upper and lower airways is that 
upper airway patency is largely influenced by vascular tone, whereas, in the lower airway, 
airflow is influenced predominantly by smooth muscle function. Despite some anatomical 
differences between asthma and rhinitis, they share common airway mucosa and epithelium 
with similar immunopathological features (Rowe-Jones, 1997). Both diseases are 






inflammatory process. Many cells and cellular elements play a role in particular, mast cells, 
eosinophils, T lymphocytes (Th2, Tregulatory), macrophages and epithelial cells (Bourdin et 
al., 2009; KleinJan, et al, 2010; Sin & Togias, 2011). Several potential mechanisms have been 
proposed to explain the interaction between the nose and the lung. Among them, some 
strong evidences suggest that not only local or neural-vascular, but also systemic induction 
of inflammatory cells is involved in this relationship. Indeed, cells (Th2 effector cells), 
cytokines, chemokines and mediators from the upper airways are drained by the systemic 
circulation and can subequently affect tissues at a distance. In this regard, bidirectional 
relationship also exists between upper and lower airways. Although the precise mechanisms 
have not yet been elucidated in naso-bronchial cross-talk, there appear to be important links 
(Fasano, 2010; Togias, 2000, 2003). 
One of them is that of a shift from nasal to mouth breathing due to the nasal congestion. In 
AR, loss of nasal warming, humidifying and filtering functions may result in an increased 
exposure of the lower airways to allergens and irritants. This condition may lead to 
inflammatory changes and an increase in BHR in susceptible subjects. As another possible 
explanations are the aspiration of nasal contents or secretions and the nasobronchial reflex 
(Alvarez et al., 2000; Togias, 1999). Today, most data suggest a systemic link between 
mucosal sites, involving bloodstream, bone marrow and the lymphoid tissues. Several 
studies using nasal allergen challenge models have demonstrated that patients with allergic 
rhinitis alone may have inflammatory changes within the lower airways such as increased 
sputum eosinophils which is suggestive as predictor of asthma (Braunstahl et al., 2001; Inal 
et al., 2008; Sin et al., 2002). In keeping with the united airways concept, it has been shown 
that provocation with relevant allergens of the nose induces lower airway inflammation. 
Indeed, Braunstahl et al., demonstrated that nasal allergen challenge results in an increase of 
eosinophils as well as increased expression of intercellular adhesion molecule-1 in both 
nasal and bronchial biopsies of allergic rhinitis patients without asthma. (Braunstahl et al., 
2001a). In another study of these authors, a decrease in the mast cell numbers in the nose has 
been detected 24 h after segmental bronchoprovocation with allergen in nonasthmatic 
patients with allergic rhinitis, interpreted as a result of enhanced degranulation. At the same 
time, there was evidence for an influx of basophils from the blood into the nasal and 
bronchial mucosa. (Braunstahl et al.,2001b). Similarly, in patients with asthma, nasal 
biopsies showed eosinophilic inflammation, even in those who do not have symptoms of 
rhinitis. (Gaga et al., 2000). 
As a similar phenomenon, segmental bronchial allergen challenge in nonasthmatic patients 
with allergic rhinitis induces increased numbers of nasal eosinophils, IL-5 expression in 
nasal epithelium and eotaxin-positive cells in nasal lamina propria (Braunstahl et al., 2000). 
Therofore, investigators concluded that the inflammatory response following allergen 
challenge is not restricted to a local effect. Systemic propogation of allergic inflammation 
from the nasal to the lower airway mucosa has been proposed to explain the rhinitis and 
asthma link (Togias, 1999, 2003). Local absorption of inflammatory mediators at the site of 
initial inflammation presumably leads to a more generalized systemic response involving 
mucosa-associated lymphoid-tissue and bone-marrow as well. (Braunstahl & Hellings, 
2006). 
Two parts of the systemic aspect are the systemic circulation and the nervous system. They 
probably include classical mediators of the acute allergic reaction, production of several 
cytokines and chemokines, the vascular endothelium and adhesion molecules, antigen-
presenting dendritic cells and their interaction with T-lymphocytes, as well as a strong bone 
www.intechopen.com
 
The Impact of Allergic Rhinitis on Asthma: Current View 
 
39 
marrow component. (Togias, 2004). Furthermore, local tissue factors, such as microbial 
stimuli and systemic inflammatory mechanisms appear to have a role in the clinical 
expression of the allergic airway diseases. Increasing evidence indicates a major 
involvement of airway epithelial cells in the pathogenesis of both rhinitis and asthma 
(Compalati et al., 2010). 
Chronic airway inflammation has been considered an important hallmark in both asthma 
and rhinitis. However, collagen deposition to upper airways is not typically observed in the 
allergic rhinitis in contrast to the bronchi. Very few studies have investigated upper and 
lower airways simultaneously. Even increased basement membrane thickness together with 
eosinophilic inflammation was also shown in the bronchial mucosa of atopic nonasthmatics 
and allergic rhinitis alone (Chakir et al., 1996). In a publication by Ediger et al., authors 
reported that infiltration of inflammatory cells particularly eosinophils both in the nasal and 
the bronchial tissues obtained from same subjects do not remarkably differ between patients 
with nasal polyp alone without BHR and asthmatic patients with nasal polyp (Ediger et al., 
2005). 
Recent studies suggest that the Staphylococcus aureus enterotoxins (SAEs) may act as 
superantigens by amplifying eosinophilic inflammation and possibly inducing local IgE 
formation in severe persistent airway disease in AERD (Kowalski et al., 2011). Bachert et al 
also reported that within the group for chronic rhinosinusitis with nasal polyp, patients with 
Th2-biased eosinophilic inflammation have increased risk of severe asthma development 
(Bachert et al., 2010). However, nasal tissue and bronchial biopsies reveal extensive 
eosinophilic infiltration and degranulated mast cells in patients with AERD. Furthermore, 
once the disease established, production of proinflammatory cytokines and Th2 type 
cytokines (IL-2, IL-3, IL-4, IL-5, IL-13, GM-CSF) have been found to be increased. Most 
patients with AERD synthesize excessive amounts of leukotrienes even before the exposure 
the disease. Recent evidences showed high expression of transforming growth factor beta 
(TGF-β) and the deposition of collagen in CRS with or without nasal polyp (Stevenson et al., 
2006). Furthermore, increased epithelial desquamation has also been detected in the lower 
airways of atopic subjects, even before the onset of clinical symptoms whereas no structural 
changes was found in the nasal mucosa of allergic patients despite the presence of 
inflammatory cells (Braunstahl et al., 2003). The reasons why remodeling appears to be less 
extensive in the nasal mucosa than in the bronchial mucosa are still unclear (Bousquet et al., 
2004). 
6. Therapeutic implications 
AR, even though not a serious disease, is a clinically relevant while it may responsible for 
some complications and affects quality of life. In a number of retrospective database 
analyses, the severity of allergic rhinitis was demonstrated to be directly correlated with 
asthma severity. Those patients whose allergic rhinitis was mild or well controlled, had 
better asthma control. Therefore, this data suggest that effective treatment of one disease 
may improve the other (Henriksen & Wenzel, 1984; Ponte et al, 2008). 
The study by Crystal-Peters et al. was a retrospective cohort design to evaluate the 
treatment effects of AR on asthma-related health care resource utilization. In their analysis, 
the risk of emergency room visit or hospitalization due to the acute asthma attacks was 
almost 50% lower for patients treated with nasal steroids or oral antihistamines compared to 






studies have demonstrated that among patients with asthma and concomitant AR, those 
receiving therapy for AR have a significantly lower risk of subsequent asthma-related events 
than those not treated. (Bousquet et al., 2005; Corren et al., 2004). 
In a study conducted by Shaaban et al, it has been shown that subjects with rhinitis 
sensitized to indoor allergens such as mites or cat, were probably at increased onset of BHR. 
The authors also reported that BHR remission was more frequent in patients with rhinitis 
treated by nasal steroids than in those not treated. (Shaaban et al., 2007). 
Although rhinosinusitis plays an important role in initiating or exacerbating asthma, there is 
no concensus whether its treatment is effective on asthma control. Some authors considered 
rhinosinusitis as a trigger factor, whereas others support the idea of comorbidity. (Smart, 
2006). In either case, rhinosinusitis has been shown to worsen the symptoms of asthma. 
Therefore, controlling upper airway infection, inflammation, and symptoms may also 
improve the asthma outcomes (Pawankar & Zernotti, 2009). Both medical therapy and sinus 
surgery has been found to have a positive impact on improvement of asthma. (Ragab et al., 
2006). 
In some cases, the presence of upper airway inflammation like sinus disease or nasal 
polyposis renders the clinical course of asthma more severe and treatment more 
cumbersome. Several studies demonstrated that appropriate treatment of sinonasal disease 
reduces lower airway symptomatology, and improves asthma control (Dixon, 2009). 
Management options for AERD are the standard medical and surgical interventions with 
complete avoidance of COX-1 inhibiting drugs or aspirin desensitization and continuously 
receiving aspirin drug (Lee et al., 2011). Patients mostly require long-term therapy with oral 
corticosteroids. Furthermore, leukotriene modifiers improve the control of asthma in 
patients using high dose inhaled corticosteroids (Bousquet et al., 2009). 
Nasal therapy has a beneficial effect on bronchial hyperresponsiveness and airway 
inflammation. (Corren et al., 1992). In a recent study, the combination of intranasal and 
intrabronchial administration of corticosteroid preparation has been resulted in the highest 
reduction of blood eosinophil count and serum ECP, and better quality of life as well. (Nair 
et al.,2010). Scichilone et al., reported that in patients with allergic rhinitis and mild asthma, 
intranasal corticosteroids caused important fall in nasal eosinophils and effective asthma 
control associated with improvement in health- related quality of life. (Scichilone et al., 
2011). However, although optimal medical treatment of allergic rhinitis is known to be a 
prerequisite for a good therapeutic result in asthma, it remains to be clarify whether early 
and timely introduction of drugs may prevent the progression to asthma. (Koh & Kim, 
2003). Allergen specific immunotherapy has demonstrated benefit in allergic rhinitis and 
allergic asthma in appropriately selected patients. It may also prevent the subsequent 
development of asthma and new sensitizations in children. (Fiocchi & Fox, 2010; Pipet et al., 
2009). Furthermore, patients with moderate to severe persistant allergic asthma has been 
observed to achieve significant additional clinical benefit for their symptoms of concomitant 
allergic rhinitis and improvement in quality of life after receiving Omalizumab, a 
recombinant, humanized, monoclonal anti-IgE antibody. (Humbert et al., 2009; Vignola et 
al., 2004). 
Better understanding of mechanisms related to inflammation in the nose and the lung has 
lead to combined therapeutic approaches targeting both diseases. (Greenberger, 2008; 
Nathan, 2009). Current ARIA guidelines strongly encourage dual evaluation of these 
patients and given therapies. Therefore, the effectively treatment of upper airway disease 
can significantly improve established asthma outcomes as well as may prevent the future 
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development of asthma (Brozek et al., 2010). Consequently, a therapy that addresses the 
systemic aspects of AR is more beneficial than a therapy with only local effects because it 
improves both AR and concomitant inflammatory disorders that might be present. (Borish, 
2003). 
It should be emphasized that because upper and lower airway diseases commonly comorbid 
conditions, it is important to consider the respiratory system as an integrated unit. By 
increasing the awareness of sinonasal and lung involvement in any patient, appropriate 
diagnostic and therapeutic options will significantly improve the level of care among those 
different specialties or primary care physicians. (Krouse et al., 2007; Rimmer & Ruhno, 
2006). 
In conclusion, elegant studies confirm that sinonasal disorders are very crucial co-
morbidities in people with asthma, and they should be treated with an integrated approach. 
Further investigations are needed to determine if early intervention of rhinitis and/or 
sinusitis could prevent or delay the onset of asthma. 
7. References 
Alvarez MJ., Olaguibel JM., & Garcia BE., et al. (2000). Comparison of allergen-induced 
changes in bronchial hyperresponsiveness and airway inflammation between 
mildly allergic asthma patients and allergic rhinitis patients. Allergy, Vol. 55, pp. 
531-539. 
Bachert C., Claeys SEM., Tomassen P., van Zele T.,& Zhang N.(2010). Rhinosinusitis and 
asthma: A link for asthma severity. Curr Allergy Asthma Rep, Vol. 10, pp. 194-201.  
 Bachert C., van Cauwenberge P., & Khaltaev N. (2002). World Health Organization. Allergic 
rhinitis and its impact on asthma. In collaboration with the World Health 
Organization. Executive summary of the workshop report. Allergy, Vol. 5, pp. 841-
855.  
Bachert C., Vignola AM., & Gevaert P., et al. (2004). Allergic rhinitis, rhinosinusitis, and 
asthma: one airway disease. Immunol Allergy Clin N Am, Vol. 24, pp: 19-43. 
Berger WE. (2003). Overview of allergic rhinitis. Ann Allergy Asthma Immunol, Vol. 90 (suppl. 
3), pp. 7-12. 
Borish L. (2003). Allergic rhinitis: Systemic inflammation and implications for management. 
J Allergy Clin Immunol, Vol. 112, pp. 1021-1031. 
Boulay M-E., & Boulet L-P. (2003). The relationship between atopy, rhinitis and asthma: 
pathophysiological considerations. Curr Opin Allergy Clin Immunol, Vol. 3, No. 1, 
pp.51-55 
Boulet L-P., Morin D., & Milot J., et al. (1989). Bronchial responsiveness increases after 
seasonal antigen exposure in non-asthmatic subjects with pollen-induced rhinitis. 
Ann Allergy, Vol. 63, pp. 114-119. 
Bourdin A., Gras D., & Vachier I., et al. (2009). Upper airway-1: Allergic rhinitis and asthma: 
United disease through epithelial cells. Thorax, Vol. 64, pp. 999-1004. 
Bousquet J., Bachert C., & Canonica GW., et al. (2009). Unmet needs in severe chronic upper 
airway disease (SCUAD). J Allergy Clin Immunol, Vol.124, pp. 428-433.  
Bousquet J., Gaugris S., & Sazonov Kocevar V., et al. (2005). Increased risk of asthma attacks 
and emergency visits among asthma patients with allergic rhinitis: a subgroup 






Bousquet J., Jacquot W., & Vignola M., et al. (2004). Allergic rhinitis: A disease remodeling 
the upper airways? J Allergy Clin Immunol, Vol. 113, pp. 43-49. 
Bousquet J., Van Cauwenberge P., & Khaltaev N. (2001). ARIA Workshop Group. World 
Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin 
Immunol, Vol. 108 (suppl 5), pp. S147-S334. 
Bousquet J., Vignola AM., & Demoly P. (2003). Links between rhinitis and asthma. Allergy, 
Vol. 58, pp. 691-706. 
Braman SS., Barrows AA., & DeCotiis BA., et al. (1987). Airway hyperresponsiveness in 
allergic rhinitis. A risk factor for asthma. Chest , Vol. 91, pp. 671-674. 
Braunstahl G-.J, & Hellings PW. (2006). Nasobronchial interaction mechanisms in allergic 
airways. Curr Opin Otolaryngol Head Neck Surg, Vol. 14, pp. 176-182. 
Braunstahl G-J. (2005). The unified immune system: Respiratory tract-nasobronchial 
interaction mechanisms in allergic airway disease. J Allergy Clin Immunol, Vol. 115, 
pp. 142-148. 
Braunstahl G-J., & Fokkens W. (2003). Nasal involvement in allergic asthma. Allergy, Vol. 58, 
pp. 1235-1243. 
Braunstahl GJ., Fokkens WJ., & Overbeek SE., et al. (2003). Mucosal and systemic 
inflammatory changes in allergic rhinitis and asthma: a comparison between upper 
and lower airways. Clin Exp Allergy, Vol. 33, pp. 579-587. 
Braunstahl GJ., Kleinjan A., & Overbeek SE., et al. (2000). Segmental bronchial provocation 
induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med, 
Vol. 161, pp. 2051-2057. 
Braunstahl GJ., Overbeek SE., & Fokkens WJ., et al. (2001b). Segmental bronchoprovocation 
in allergic rhinitis patients affects mast cell and basophil numbers in nasal and 
bronchial mucosa. Am J Respir Crit Care Med, Vol. 164, pp. 858-865. 
Braunstahl GJ., Overbeek SE., & Kleinjan A., et al. (2001a). Nasal allergen provocation 
induces adhesion molecule expression and tissue eosinophilia in upper and lower 
airways. J Allergy Clin Immunol, Vol. 107, pp. 469-476. 
Brozek JL., Bousquet J., & Baena-Cagnani CE., et al. (2010). Allergic rhinitis and its impact 
on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol, Vol.126, pp. 
466-476. 
Ceylan E., Gencer M., & San I. (2007). Nasal polyps and the severity of asthma. Respirology, 
Vol.12, pp. 272-276. 
Chakir J., Laviolette M., & Boutet M., et al. (1996). Lower airways remodeling in 
nonasthmatic subjects with allergic rhinitis. Lab Invest, Vol. 75, pp. 735-744. 
Ciprandi G., & Passalacqua G. (2008). Allergy and the nose. Clin Exp Immunol, Vol. 153 
(suppl. 1), pp. 22-26. 
Ciprandi G., Cirillo I., & Tosca MA., et al. (2004). Bronchial hyperreactivity and spirometric 
impairment in patients with perennial allergic rhinitis. Int Arc Allergy Immunol, Vol. 
133, pp. 14-18. 
Cirillo I., Pistorio A., & Tosca M., et al. (2009). Impact of allergic rhinitis on asthma: effects 
on bronchial hyperreactivity. Allergy, Vol. 64, pp. 439-444. 
Compalati E., Ridolo E., & Passalacqua G., et al. (2010). The link between allergic rhinitis 




The Impact of Allergic Rhinitis on Asthma: Current View 
 
43 
Corren J. (1997). Allergic rhinitis and asthma: How important is the link? J Allergy Clin 
Immunol, Vol. 99, pp. S781-786.  
Corren J., Adinoff AD., & Buchmeier AD., et al. (1992). Nasal beclomethasone prevents the 
seasonal increase in bronchial responsiveness in patients with allergic rhinitis and 
asthma. J Allergy Clin Immunol, Vol. 90, pp. 250-256. 
Corren J., Manning BE., & Thompson SF., et al. (2004). Rhinitis therapy and the prevention 
of hospital care for asthma: a case-control study. J Allergy Clin Immunol, Vol. 113, 
pp. 415-419. 
Crystal-Peters J., Neslusan C., & Crown WH., et al. (2002). Treating allergic rhinitis in 
patients with comorbid asthma: the risk of asthma-related hospitalizations and 
emergency department visits. J Allergy Clin Immunol, Vol. 109, pp. 57-62. 
Danielsson J., & Jessen M. (1997). The natural course of allergic rhinitis during 12 years of 
follow-up. Allergy, Vol. 52, pp. 331-334.  
Dixon AE. (2009). Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med, Vol. 15, 
pp. 19-24. 
Dursun AB., Sin BA., & Dursun E., et al. (2006). Clinical aspects of the link between chronic 
sinonasal diseases and asthma. Allergy Asthma Proc, Vol. 27, pp. 510-515. 
Ediger D., Sin BA., & Heper A., et al. (2005). Airway inflammation in nasal polyposis: 
immunopathological aspects of relation to asthma. Clin Exp Allergy, Vol. 35, pp. 
319-326. 
Fasano MB. (2010). Combined airways: impact of upper airway on lower airway. Curr Opin 
Otolaryngol Head Neck Surg, Vol. 18, pp.15-20. 
Fiocchi A., & Fox AT. (2010). Preventing progression of allergic rhinitis: the role of specific 
immunotherapy. Arch Dis Child Educ Pract Ed. Published online November 3,2010. 
doi: 10.1136/adc.2010.183095. 
Foresi A., Leone C., & Pelucchi A., et al. (1997). Eosinophils, mast cells, and basophils in 
induced sputum from patients with seasonal allergic rhinitis and perennial asthma: 
relationship to methacholine responsiveness. J Allergy Clin Immunol, Vol. 100, pp. 
58-64. 
Gaga M., Lambrou P., & Papageorgiou N., et al. (2000). Eosinophils are a feature of upper 
and lower airway pathology in non-atopic asthma, irrespective of the presence of 
rhinitis. Clin Exp Allergy, Vol. 30, pp. 663-669. 
Greenberger PA. (2008). Allergic rhinitis and asthma connection: Treatment implications. 
Allergy Asthma Proc, Vol. 29, pp. 557-64. 
Guerra S., Sherrill D.,& Martinez FD., et al. (2002). Rhinitis as an independent risk factor for 
adult-onset asthma. J Allergy Clin Immunol, Vol. 109, pp. 419-425. 
Hanes LS., Issa E., & Proud D., et al. (2006). Stronger nasal responsiveness to cold air in 
individuals with rhinitis and asthma, compared to rhinitis alone. Clin Exp Allergy, 
Vol. 36, pp. 26-31. 
Henriksen JM., & Wenzel A. (1984). Effect of an intranasally administered corticosteroid 
(budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir 
Dis, Vol. 130, pp. 1014-1018.  
Humbert M., Boulet LP., & Niven RM., et al. (2009). Omalizumab therapy: patients who 
achieve greatest benefit for their asthma experience greatest benefit for rhinitis. 






Huovinen E., Kaprio J., & Laitinen LA., et al. (1999). Incidence and prevalence of asthma 
among adults Finnish men and women of the Finnish Twin Cohort from 1975 to 
1990, and theirrelation to hay fever and chronic bronchitis. Chest, Vol. 115, pp. 928-
936. 
Illi S., Von Mutius E., & Lau S., et al. (2004). The natural course of atopic dermatitis from 
birth to age 7 years and the association with asthma. J Allergy Clin Immunol, Vol. 
113, pp. 925-31. 
Inal A., Kendirli SG., & Yilmaz M., et al. (2008). Indices of lower airway inflammation in 
children monosensitized to house dust mite after nasal allergen challenge. Allergy, 
Vol. 63, pp. 1345-1351. 
Kapsali T., Horowitz E., & Togias A. (1997). Rhinitis is ubiquitous in allergic asthmatics. J 
Allergy Clin Immunol, Vol. 99, pp. S138. 
KleinJan A., Willart M., & van Nimwegen M., et al. (2010). United airways: circulating Th2 
effector cells in an allergic rhinitis model are responsible for promoting lower 
airways inflammation. Clin Exp Allergy, Vol. 40, pp. 494-504. 
Koh YY., & Kim CK. (2003). The development of asthma in patients with allergic rhinitis. 
Curr Opin Allergy Clin Immunol, Vol. 3, pp. 159-164.  
Kowalski ML., Cieslak M., Perez-Novo CA., Makowska JS., & Bachert C. (2011). Clinical and 
immunological determinants of severe/refractory asthma (SRA): association with 
staphylococcal superantigen-specific IgE antibodies. Allergy, Vol. 66 (1), pp. 32-38. 
Krouse JH., Veling MC., & Ryan MW., et al. (2007). Executive summary: Asthma and the 
unified airway. Otolaryngology-Head Neck Surgery, Vol. 136, pp. 699-706.  
Lau S., Nickel R., & Niggemann B., et al. (2002). The development of childhood asthma: 
lessons from the German Multicentre Allergy Study (MAS). Paed Resp Rev, Vol. 3, 
pp. 265-272. 
Lee RU.,& Stevenson DD. (2011). Aspirin-exacerbated respiratory disease: Evaluation and 
management. Allergy Asthma Immunol Res, Vol. 3 (1), pp. 3-10. 
Leynaert B., Bousquet J., & Neukirch C., et al. (1999). Perennial rhinitis: an independent risk 
factor for asthma in nonatopic subjects: results from the European Community 
Respiratory Health Survey. J Allergy Clin Immunol, Vol. 104, pp. 301-304. 
Leynaert B., Neukirch F., & Demoly P., et al. (2000). Epidemiologic evidence for asthma and 
rhinitis comorbidity. J Allergy Clin Immunol, Vol. 106, pp. S201-205. 
Linneberg A., Nielsen NH., & Madsen F., et al. (2001). Secular trends of allergic asthma in 
Danish adults. The Copenhagen Allergy Study. Respir Med, Vol. 95, pp. 258-264. 
Madonini E., Briatico-Vangosa G., & Pappacoda A., et al. (1987). Seasonal increase of 
bronchial reactivity in allergic rhinitis. J Allergy Clin Immunol, Vol. 79, pp. 358-363. 
Marple BF. (2010). Allergic rhinitis and inflammatory airway disease: interactions within the 
unified airspace. Am J Rhinol, Vol. 24, pp. 249-54. 
McFadden ERJr. (1986). Nasal-sinus-pulmonary reflexes and bronchial asthma. J Allergy Clin 
Immunol, Vol. 78 pp. 1-3.  
Meltzer EO., Svwarcberg J., & Pill MW. (2004). Allergic rhinitis, asthma, and rhinosinusitis: 
Diseases of the integrated airway. J Manag Care Pharm, Vol. 10, pp. 310-317. 
Nair A., Vaidyanathan S., & Clearie K., et al. (2010). Steroid sparing effects of intranasal 
corticosteroids in asthma and allergic rhinitis. Allergy, Vol. 65, pp. 359-67. 
Nathan RA. (2009). Management of patients with allergic rhinitis and asthma: literature 
review. South Med J, Vol. 102, pp. 935-941. 
www.intechopen.com
 
The Impact of Allergic Rhinitis on Asthma: Current View 
 
45 
Pawankar R. (2006). Allergic rhinitis and asthma: are they manifestations of one syndrome? 
Clin Exp Allergy, Vol. 36, pp. 1-6. 
Pawankar R., & Zernotti ME. (2009). Rhinosinusitis in children and asthma severity. Curr 
Opin Allergy Clin Immunol, Vol. 9, pp. 151-153. 
Pearlman AN., Chandra RK., & Chang D., et al. (2009). Relationship between severity of 
chronic rhinosinusitis and nasal polyposis, asthma, and atopy. Am J Rhinol Allergy, 
Vol. 23, pp. 145-148. 
Peroni DG., Piacentini GL., & Ceravolo R., et al. (2007). Difficult asthma: possible association 
with rhinosinusitis. Pediatr Allergy Immunol, Vol. 18 (suppl.18), pp. 25-27. 
Pipet A., Botturi K., & Pinot D., et al. (2009). Allergen-specific immunotherapy in allergic 
rhinitis and asthma. Mechanisms and proof of efficacy. Respir Med, Vol. 103, pp. 
800-12.  
Polosa R., Ciamarra I., & Mangano G., et al. (2000). Bronchial hyperresponsiveness and 
airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J, 
Vol. 15, pp. 30-35. 
Ponte EV., Franco R., & Nascimento HF., et al. (2008). Lack of control of severe asthma is 
associated with co-existence of moderate-to-severe rhinitis. Allergy, Vol. 63, pp. 564-
569. 
Prieto L., Uixera S., & Gutierrez V., et al. (2002). Modifications of airway responsivenss to 
adenosine 5´-monophosphate and exhaled nitric oxide concentrations after the 
pollen season in subjects with pollen-induced rhinitis. Chest, Vol. 122, pp. 940-947. 
Ragab S., Scadding GK., & Lund VJ., et al. (2006). Treatment of chronic rhinosinusitis and its 
effects on asthma. Eur Respir J, Vol. 28, pp. 68-74.  
Ramsdale EH., Morris MM., & Robers RS., et al. (1985). Asymptomatic bronchial 
hyperresponsiveness in rhinitis. J Allergy Clin Immunol, Vol. 75, pp. 573-577. 
Rimmer J., & Ruhno JW. (2006). Rhinitis and asthma: united airway disease. MJA Practice 
Essentials-Allergy, Vol. 185, No.10, pp. 565-571. 
Rowe-Jones JM. (1997). The link between the nose and lung,perennial rhinitis and asthma- is 
it the same disease? Allergy, Vol. 52 (suppl. 36), pp. 20-28. 
Scichilone N., Arrigo R., & Paterno A., et al. (2011). The effect of intranasal corticosteroids on 
asthma control and quality of life in allergic rhinitis with mild asthma. J Asthma, 
Vol. 48, pp. 41-47. 
Settipane RA. (2003). Rhinitis: A dose of epidemiologic reality. Allergy Asthma Proc, Vol. 24, 
pp. 147-154. 
Settipane RJ., Hagy GW., & Settipane GA. (1994). Long-term risk factors for developing 
asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy 
Proc, Vol. 15, pp. 21-25. 
Shaaban R., Zureik M., & Soussan D., et al. (2007). Allergic rhinitis and onset of bronchial 
hyperresponsiveness: a population-based study. Am J Respir Crit Care Med, Vol. 176, 
pp. 659-66.  
Shaaban R., Zureik M., & Soussan D., et al. (2008). Rhinitis and onset of asthma: a 
longitudinal population-based study. Lancet, Vol. 372, pp. 1049-1057. 
Sin B., & Togias A. (2011). Pathophysiology of allergic and nonallergic rhinitis. Proc Am 






Sin B., Wu X., & Hoenig T., et al. (2002). Nasal allergen challenge induces inflammatory cell 
influx in sputum and peripheral eosinophilia. J Allergy Clin Immunol, Vol. 109, pp. 
S100-S101. 
Sin BA., Yıldız OA., & Dursun AB., et al. (2009). Airway hyperresponsiveness: a 
comparative study of methacholine and exercise challenges in seasonal allergic 
rhinitis with or without asthma. J Asthma, Vol. 46, pp. 486-491. 
Skloot G., & Togias A. (2003). Bronchodilation and bronchoprotection by deep inspiration 
and their relationship to bronchial hyperresponsiveness. Clin Rev Allergy Immunol, 
Vol. 24, pp. 55-72. 
Slavin RG. (2008). The upper and lower airways: the epidemiological and 
pathophysiological connection. Allergy Asthma Proc, Vol. 29, pp. 553-56. 
Smart BA. (2006). Is rhinosinusitis a cause of asthma? Clin Rev Allergy Immunol, Vol. 30, pp. 
153-164.  
Spector SL. (1997). Overview of comorbid associations of allergic rhinitis. J Allergy Clin 
Immunol, Vol. 99, pp. S773-S780. 
Spergel JM. (2005). Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol, 
Vol. 5, pp. 17-21. 
Stevenson DD., & Szczeklik A. (2006). Clinical and pathologic perspectives on aspirin 
sensitivity and asthma. J Allergy Clin Immunol, Vol. 118, pp. 773-786.  
Szczeklik A., Nizankowska M., & Duplaga M., on behalf of the AIANE Investigators. (2000). 
Natural history of aspirin-induced asthma. Eur Respir J, Vol. 16, pp.432-436.  
Togias A. (1999). Mechanisms of nose-lung interaction. Allergy, Vol. 54 (suppl. 57), pp. 94-
105. 
Togias A. (2003). Rhinitis and asthma: evidence for respiratory system integration. J Allergy 
Clin Immunol, Vol. 111, pp. 1171-1183. 
Togias A. (2004). Systemic effects of local allergic disease. J Allergy Clin Immunol, Vol. 113, 
pp. S8-S14. 
Togias AG. (2000). Systemic immunologic and inflammatory aspects of allergic rhinitis. J 
Allergy Clin Immunol, Vol. 106 (suppl. 5), pp. S247-S250. 
Vignola AM., Humbert M., & Bousquet J., et al. (2004). Efficacy and tolerability of anti-
immunoglobulin E therapy with omalizumab in patients with concomitant allergic 
asthma and persistent allergic rhinitis: SOLAR. Allergy, Vol. 59, pp. 709-717. 
www.intechopen.com
Allergic Rhinitis
Edited by Prof. Marek Kowalski
ISBN 978-953-51-0288-5
Hard cover, 214 pages
Publisher InTech
Published online 21, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Allergic rhinitis, while troublesome for a patient, may be also a challenge for the physician. That is why
physicians must still learn more on the pathophysiology, clinical spectrum and novel diagnostic and therapeutic
approaches to the disease. The chapters of this volume address a variety of important topics related to allergic
rhinitis. They begin with a description of innovative translational approaches allowing for unification of animal
and human models. Contributing authors provide up-to-date reviews of clinical aspects of allergic rhinitis in
children, its association with bronchial asthma and other co-morbid conditions. They also discuss the impact of
allergic rhinitis on sleep and sports. Together with articles on diagnostic approaches as well as novel
treatments, the book offers a comprehensive and stimulating review of the topic. May this book find a wide
readership among allergists and other physicians interested in allergic disease, and also among pediatricians,
general practitioners and other specialists who increasingly have to deal with this seemingly benign, but
sometimes extremely troublesome, disease.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Betül Ayşe Sin (2012). The Impact of Allergic Rhinitis on Asthma: Current View, Allergic Rhinitis, Prof. Marek
Kowalski (Ed.), ISBN: 978-953-51-0288-5, InTech, Available from: http://www.intechopen.com/books/allergic-
rhinitis/the-impact-of-allergic-rhinitis-on-asthma
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
